FDA Device Intelligence
Home › AESTHETIC TECHNOLOGY LTD › Dermalux

Dermalux

AESTHETIC TECHNOLOGY LTD · Model Flex MD · UDI-DI 05060762460028

GEXILY
10
510(k) clearances
44,034
Adverse events (107 deaths)
201
Recalls
487
Facilities

Description

The Dermalux® Flex MD is a Medical Device for use on a treatment bed/surface. The device emits specific wavelengths of low level, narrow band light for the treatment of certain cosmetic, dermatological and medical indications. The wavelengths used in the Dermalux® Flex MD system are Blue 415nm, Red 633nm and Near Infrared 830nm.

Recalls

DateFirmReason
2026-08-06Lutronic CorporationUtilizing higher fluences at 1064nm wavelength with current cryogen parameters may result in a spark/loud noise during treatment, potentially resulting in patient burn.
2026-05-05IPG Medical CorporationSoftware anomaly that causes a false display of error code 5018.
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-02-27Olympus Corporation of the AmericasFollowing a complaint investigation, Olympus identified a potential defect in the 24V power supply module in some SOLTIVE laser units which may cause the system to become inoperabl
2026-01-27Lutronic CorporationReports of devices sparking/popping and potentially burning patients.
2025-12-15LEASEIR TECHNOLOGIES SLUThe console label for affected devices is missing the "DANGER" symbol.
2025-07-22LUMENIS, LTD.The potential for unsterilized product within finished product labeled as sterile.
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or
2025-05-06Olympus Corporation of the AmericasPotential for thermal incident including an unexpected occurrence of smoke, sparks, burning, or unsteady flames during clinical use. The fracturing of the fiber is the cause of, or

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.